nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—UGT1A1—Etoposide—sarcoma	0.0236	1	CbGbCtD
Ezogabine—Nystagmus—Vincristine—sarcoma	0.015	0.0154	CcSEcCtD
Ezogabine—Skin discolouration—Thiotepa—sarcoma	0.0134	0.0137	CcSEcCtD
Ezogabine—Gait disturbance—Vincristine—sarcoma	0.011	0.0113	CcSEcCtD
Ezogabine—Coma—Vincristine—sarcoma	0.00981	0.01	CcSEcCtD
Ezogabine—Skin discolouration—Etoposide—sarcoma	0.00963	0.00986	CcSEcCtD
Ezogabine—Urinary retention—Thiotepa—sarcoma	0.00836	0.00856	CcSEcCtD
Ezogabine—Liver function test abnormal—Dactinomycin—sarcoma	0.00805	0.00825	CcSEcCtD
Ezogabine—Dysphagia—Dactinomycin—sarcoma	0.00754	0.00772	CcSEcCtD
Ezogabine—Urinary retention—Vincristine—sarcoma	0.00741	0.00759	CcSEcCtD
Ezogabine—Hypokinesia—Epirubicin—sarcoma	0.00722	0.0074	CcSEcCtD
Ezogabine—Dysuria—Thiotepa—sarcoma	0.0071	0.00728	CcSEcCtD
Ezogabine—Neutropenia—Dactinomycin—sarcoma	0.00705	0.00722	CcSEcCtD
Ezogabine—Weight increased—Thiotepa—sarcoma	0.00691	0.00708	CcSEcCtD
Ezogabine—Nystagmus—Epirubicin—sarcoma	0.00683	0.00699	CcSEcCtD
Ezogabine—Infestation NOS—Thiotepa—sarcoma	0.00677	0.00694	CcSEcCtD
Ezogabine—Infestation—Thiotepa—sarcoma	0.00677	0.00694	CcSEcCtD
Ezogabine—Hypokinesia—Doxorubicin—sarcoma	0.00668	0.00684	CcSEcCtD
Ezogabine—Haematuria—Thiotepa—sarcoma	0.00646	0.00662	CcSEcCtD
Ezogabine—Hepatobiliary disease—Thiotepa—sarcoma	0.00641	0.00656	CcSEcCtD
Ezogabine—Nystagmus—Doxorubicin—sarcoma	0.00632	0.00647	CcSEcCtD
Ezogabine—Dysuria—Vincristine—sarcoma	0.0063	0.00645	CcSEcCtD
Ezogabine—Neutropenia—Vincristine—sarcoma	0.0063	0.00645	CcSEcCtD
Ezogabine—Neutropenia—Mitoxantrone—sarcoma	0.00614	0.00628	CcSEcCtD
Ezogabine—Hallucination—Thiotepa—sarcoma	0.00605	0.0062	CcSEcCtD
Ezogabine—Urinary tract disorder—Thiotepa—sarcoma	0.00601	0.00615	CcSEcCtD
Ezogabine—Weight increased—Mitoxantrone—sarcoma	0.00597	0.00612	CcSEcCtD
Ezogabine—Urethral disorder—Thiotepa—sarcoma	0.00596	0.00611	CcSEcCtD
Ezogabine—Eye disorder—Thiotepa—sarcoma	0.00568	0.00582	CcSEcCtD
Ezogabine—Haematuria—Mitoxantrone—sarcoma	0.00558	0.00571	CcSEcCtD
Ezogabine—Dysphagia—Etoposide—sarcoma	0.00546	0.00559	CcSEcCtD
Ezogabine—Skin discolouration—Epirubicin—sarcoma	0.0054	0.00553	CcSEcCtD
Ezogabine—Alopecia—Thiotepa—sarcoma	0.00537	0.0055	CcSEcCtD
Ezogabine—Hallucination—Vincristine—sarcoma	0.00537	0.0055	CcSEcCtD
Ezogabine—Alopecia—Dactinomycin—sarcoma	0.00533	0.00546	CcSEcCtD
Ezogabine—Mental disorder—Thiotepa—sarcoma	0.00533	0.00546	CcSEcCtD
Ezogabine—Urinary tract disorder—Vincristine—sarcoma	0.00533	0.00545	CcSEcCtD
Ezogabine—Malnutrition—Thiotepa—sarcoma	0.00529	0.00542	CcSEcCtD
Ezogabine—Urethral disorder—Vincristine—sarcoma	0.00529	0.00541	CcSEcCtD
Ezogabine—Dysarthria—Epirubicin—sarcoma	0.00516	0.00528	CcSEcCtD
Ezogabine—Neutropenia—Etoposide—sarcoma	0.0051	0.00523	CcSEcCtD
Ezogabine—Gait disturbance—Epirubicin—sarcoma	0.005	0.00512	CcSEcCtD
Ezogabine—Skin discolouration—Doxorubicin—sarcoma	0.00499	0.00512	CcSEcCtD
Ezogabine—Vision blurred—Thiotepa—sarcoma	0.00499	0.00511	CcSEcCtD
Ezogabine—Coordination abnormal—Epirubicin—sarcoma	0.00497	0.00509	CcSEcCtD
Ezogabine—Ill-defined disorder—Dactinomycin—sarcoma	0.00487	0.00499	CcSEcCtD
Ezogabine—Infestation NOS—Etoposide—sarcoma	0.00487	0.00498	CcSEcCtD
Ezogabine—Infestation—Etoposide—sarcoma	0.00487	0.00498	CcSEcCtD
Ezogabine—Dysarthria—Doxorubicin—sarcoma	0.00477	0.00489	CcSEcCtD
Ezogabine—Alopecia—Vincristine—sarcoma	0.00476	0.00488	CcSEcCtD
Ezogabine—Leukopenia—Thiotepa—sarcoma	0.00474	0.00485	CcSEcCtD
Ezogabine—Malaise—Dactinomycin—sarcoma	0.00474	0.00485	CcSEcCtD
Ezogabine—Mental disorder—Vincristine—sarcoma	0.00472	0.00484	CcSEcCtD
Ezogabine—Leukopenia—Dactinomycin—sarcoma	0.0047	0.00482	CcSEcCtD
Ezogabine—Alopecia—Mitoxantrone—sarcoma	0.00464	0.00475	CcSEcCtD
Ezogabine—Gait disturbance—Doxorubicin—sarcoma	0.00462	0.00473	CcSEcCtD
Ezogabine—Hepatobiliary disease—Etoposide—sarcoma	0.0046	0.00471	CcSEcCtD
Ezogabine—Coordination abnormal—Doxorubicin—sarcoma	0.00459	0.00471	CcSEcCtD
Ezogabine—Anxiety—Thiotepa—sarcoma	0.00449	0.0046	CcSEcCtD
Ezogabine—Coma—Epirubicin—sarcoma	0.00446	0.00456	CcSEcCtD
Ezogabine—Discomfort—Dactinomycin—sarcoma	0.00442	0.00453	CcSEcCtD
Ezogabine—Confusional state—Thiotepa—sarcoma	0.00436	0.00446	CcSEcCtD
Ezogabine—Urinary tract disorder—Etoposide—sarcoma	0.00431	0.00442	CcSEcCtD
Ezogabine—Vision blurred—Mitoxantrone—sarcoma	0.00431	0.00441	CcSEcCtD
Ezogabine—Infection—Thiotepa—sarcoma	0.00429	0.0044	CcSEcCtD
Ezogabine—Urethral disorder—Etoposide—sarcoma	0.00428	0.00439	CcSEcCtD
Ezogabine—Infection—Dactinomycin—sarcoma	0.00426	0.00436	CcSEcCtD
Ezogabine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00424	0.00434	CcSEcCtD
Ezogabine—Nervous system disorder—Thiotepa—sarcoma	0.00424	0.00434	CcSEcCtD
Ezogabine—Thrombocytopenia—Thiotepa—sarcoma	0.00423	0.00433	CcSEcCtD
Ezogabine—Vertigo—Vincristine—sarcoma	0.00422	0.00432	CcSEcCtD
Ezogabine—Leukopenia—Vincristine—sarcoma	0.0042	0.0043	CcSEcCtD
Ezogabine—Thrombocytopenia—Dactinomycin—sarcoma	0.0042	0.0043	CcSEcCtD
Ezogabine—Malaise—Mitoxantrone—sarcoma	0.00412	0.00422	CcSEcCtD
Ezogabine—Coma—Doxorubicin—sarcoma	0.00412	0.00422	CcSEcCtD
Ezogabine—Leukopenia—Mitoxantrone—sarcoma	0.00409	0.00419	CcSEcCtD
Ezogabine—Eye disorder—Etoposide—sarcoma	0.00408	0.00418	CcSEcCtD
Ezogabine—Paraesthesia—Thiotepa—sarcoma	0.00388	0.00397	CcSEcCtD
Ezogabine—Anxiety—Mitoxantrone—sarcoma	0.00388	0.00397	CcSEcCtD
Ezogabine—Alopecia—Etoposide—sarcoma	0.00386	0.00395	CcSEcCtD
Ezogabine—Discomfort—Mitoxantrone—sarcoma	0.00385	0.00394	CcSEcCtD
Ezogabine—Somnolence—Thiotepa—sarcoma	0.00384	0.00393	CcSEcCtD
Ezogabine—Infection—Vincristine—sarcoma	0.00381	0.0039	CcSEcCtD
Ezogabine—Dyspepsia—Thiotepa—sarcoma	0.0038	0.0039	CcSEcCtD
Ezogabine—Increased appetite—Epirubicin—sarcoma	0.00377	0.00386	CcSEcCtD
Ezogabine—Confusional state—Mitoxantrone—sarcoma	0.00376	0.00385	CcSEcCtD
Ezogabine—Nervous system disorder—Vincristine—sarcoma	0.00376	0.00385	CcSEcCtD
Ezogabine—Thrombocytopenia—Vincristine—sarcoma	0.00375	0.00384	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00373	0.00382	CcSEcCtD
Ezogabine—Fatigue—Thiotepa—sarcoma	0.00372	0.00381	CcSEcCtD
Ezogabine—Infection—Mitoxantrone—sarcoma	0.00371	0.0038	CcSEcCtD
Ezogabine—Hyperhidrosis—Vincristine—sarcoma	0.0037	0.00379	CcSEcCtD
Ezogabine—Fatigue—Dactinomycin—sarcoma	0.0037	0.00379	CcSEcCtD
Ezogabine—Constipation—Thiotepa—sarcoma	0.00369	0.00378	CcSEcCtD
Ezogabine—Shock—Mitoxantrone—sarcoma	0.00367	0.00376	CcSEcCtD
Ezogabine—Muscle spasms—Etoposide—sarcoma	0.00366	0.00374	CcSEcCtD
Ezogabine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00365	0.00374	CcSEcCtD
Ezogabine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00361	0.00369	CcSEcCtD
Ezogabine—Feeling abnormal—Thiotepa—sarcoma	0.00356	0.00365	CcSEcCtD
Ezogabine—Diplopia—Epirubicin—sarcoma	0.00354	0.00363	CcSEcCtD
Ezogabine—Osteoarthritis—Epirubicin—sarcoma	0.00354	0.00363	CcSEcCtD
Ezogabine—Feeling abnormal—Dactinomycin—sarcoma	0.00353	0.00362	CcSEcCtD
Ezogabine—Ill-defined disorder—Etoposide—sarcoma	0.00353	0.00361	CcSEcCtD
Ezogabine—Increased appetite—Doxorubicin—sarcoma	0.00349	0.00357	CcSEcCtD
Ezogabine—Paraesthesia—Vincristine—sarcoma	0.00344	0.00352	CcSEcCtD
Ezogabine—Malaise—Etoposide—sarcoma	0.00343	0.00351	CcSEcCtD
Ezogabine—Vertigo—Etoposide—sarcoma	0.00342	0.0035	CcSEcCtD
Ezogabine—Leukopenia—Etoposide—sarcoma	0.0034	0.00349	CcSEcCtD
Ezogabine—Paraesthesia—Mitoxantrone—sarcoma	0.00335	0.00343	CcSEcCtD
Ezogabine—Loss of consciousness—Etoposide—sarcoma	0.00334	0.00342	CcSEcCtD
Ezogabine—Dyspnoea—Mitoxantrone—sarcoma	0.00333	0.00341	CcSEcCtD
Ezogabine—Somnolence—Mitoxantrone—sarcoma	0.00332	0.0034	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Vincristine—sarcoma	0.00331	0.00339	CcSEcCtD
Ezogabine—Fatigue—Vincristine—sarcoma	0.0033	0.00338	CcSEcCtD
Ezogabine—Dyspepsia—Mitoxantrone—sarcoma	0.00328	0.00336	CcSEcCtD
Ezogabine—Constipation—Vincristine—sarcoma	0.00328	0.00336	CcSEcCtD
Ezogabine—Osteoarthritis—Doxorubicin—sarcoma	0.00327	0.00335	CcSEcCtD
Ezogabine—Diplopia—Doxorubicin—sarcoma	0.00327	0.00335	CcSEcCtD
Ezogabine—Liver function test abnormal—Epirubicin—sarcoma	0.00327	0.00335	CcSEcCtD
Ezogabine—Fatigue—Mitoxantrone—sarcoma	0.00322	0.00329	CcSEcCtD
Ezogabine—Discomfort—Etoposide—sarcoma	0.0032	0.00328	CcSEcCtD
Ezogabine—Constipation—Mitoxantrone—sarcoma	0.00319	0.00327	CcSEcCtD
Ezogabine—Confusional state—Etoposide—sarcoma	0.00313	0.0032	CcSEcCtD
Ezogabine—Asthenia—Thiotepa—sarcoma	0.0031	0.00317	CcSEcCtD
Ezogabine—Infection—Etoposide—sarcoma	0.00308	0.00316	CcSEcCtD
Ezogabine—Asthenia—Dactinomycin—sarcoma	0.00308	0.00315	CcSEcCtD
Ezogabine—Feeling abnormal—Mitoxantrone—sarcoma	0.00307	0.00315	CcSEcCtD
Ezogabine—Influenza—Epirubicin—sarcoma	0.00306	0.00313	CcSEcCtD
Ezogabine—Dysphagia—Epirubicin—sarcoma	0.00306	0.00313	CcSEcCtD
Ezogabine—Thrombocytopenia—Etoposide—sarcoma	0.00304	0.00311	CcSEcCtD
Ezogabine—Liver function test abnormal—Doxorubicin—sarcoma	0.00302	0.0031	CcSEcCtD
Ezogabine—Hyperhidrosis—Etoposide—sarcoma	0.003	0.00307	CcSEcCtD
Ezogabine—Dysuria—Epirubicin—sarcoma	0.00286	0.00293	CcSEcCtD
Ezogabine—Neutropenia—Epirubicin—sarcoma	0.00286	0.00293	CcSEcCtD
Ezogabine—Dizziness—Thiotepa—sarcoma	0.00286	0.00293	CcSEcCtD
Ezogabine—Influenza—Doxorubicin—sarcoma	0.00283	0.0029	CcSEcCtD
Ezogabine—Dysphagia—Doxorubicin—sarcoma	0.00283	0.0029	CcSEcCtD
Ezogabine—Paraesthesia—Etoposide—sarcoma	0.00279	0.00285	CcSEcCtD
Ezogabine—Weight increased—Epirubicin—sarcoma	0.00278	0.00285	CcSEcCtD
Ezogabine—Dyspnoea—Etoposide—sarcoma	0.00277	0.00283	CcSEcCtD
Ezogabine—Somnolence—Etoposide—sarcoma	0.00276	0.00283	CcSEcCtD
Ezogabine—Asthenia—Vincristine—sarcoma	0.00275	0.00282	CcSEcCtD
Ezogabine—Infestation NOS—Epirubicin—sarcoma	0.00273	0.00279	CcSEcCtD
Ezogabine—Infestation—Epirubicin—sarcoma	0.00273	0.00279	CcSEcCtD
Ezogabine—Rash—Thiotepa—sarcoma	0.00272	0.00279	CcSEcCtD
Ezogabine—Dermatitis—Thiotepa—sarcoma	0.00272	0.00279	CcSEcCtD
Ezogabine—Rash—Dactinomycin—sarcoma	0.0027	0.00277	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Etoposide—sarcoma	0.00268	0.00274	CcSEcCtD
Ezogabine—Asthenia—Mitoxantrone—sarcoma	0.00268	0.00274	CcSEcCtD
Ezogabine—Fatigue—Etoposide—sarcoma	0.00268	0.00274	CcSEcCtD
Ezogabine—Constipation—Etoposide—sarcoma	0.00265	0.00272	CcSEcCtD
Ezogabine—Neutropenia—Doxorubicin—sarcoma	0.00265	0.00271	CcSEcCtD
Ezogabine—Dysuria—Doxorubicin—sarcoma	0.00265	0.00271	CcSEcCtD
Ezogabine—Haematuria—Epirubicin—sarcoma	0.0026	0.00266	CcSEcCtD
Ezogabine—Hepatobiliary disease—Epirubicin—sarcoma	0.00258	0.00264	CcSEcCtD
Ezogabine—Weight increased—Doxorubicin—sarcoma	0.00258	0.00264	CcSEcCtD
Ezogabine—Nausea—Thiotepa—sarcoma	0.00257	0.00263	CcSEcCtD
Ezogabine—Feeling abnormal—Etoposide—sarcoma	0.00256	0.00262	CcSEcCtD
Ezogabine—Nausea—Dactinomycin—sarcoma	0.00255	0.00261	CcSEcCtD
Ezogabine—Dizziness—Vincristine—sarcoma	0.00253	0.00259	CcSEcCtD
Ezogabine—Infestation NOS—Doxorubicin—sarcoma	0.00252	0.00258	CcSEcCtD
Ezogabine—Infestation—Doxorubicin—sarcoma	0.00252	0.00258	CcSEcCtD
Ezogabine—Urinary tract disorder—Epirubicin—sarcoma	0.00242	0.00248	CcSEcCtD
Ezogabine—Rash—Vincristine—sarcoma	0.00242	0.00247	CcSEcCtD
Ezogabine—Dermatitis—Vincristine—sarcoma	0.00241	0.00247	CcSEcCtD
Ezogabine—Oedema peripheral—Epirubicin—sarcoma	0.00241	0.00247	CcSEcCtD
Ezogabine—Haematuria—Doxorubicin—sarcoma	0.00241	0.00246	CcSEcCtD
Ezogabine—Urethral disorder—Epirubicin—sarcoma	0.0024	0.00246	CcSEcCtD
Ezogabine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00239	0.00244	CcSEcCtD
Ezogabine—Visual impairment—Epirubicin—sarcoma	0.00236	0.00242	CcSEcCtD
Ezogabine—Rash—Mitoxantrone—sarcoma	0.00235	0.00241	CcSEcCtD
Ezogabine—Dermatitis—Mitoxantrone—sarcoma	0.00235	0.00241	CcSEcCtD
Ezogabine—Eye disorder—Epirubicin—sarcoma	0.00229	0.00234	CcSEcCtD
Ezogabine—Nausea—Vincristine—sarcoma	0.00228	0.00233	CcSEcCtD
Ezogabine—Urinary tract disorder—Doxorubicin—sarcoma	0.00224	0.00229	CcSEcCtD
Ezogabine—Oedema peripheral—Doxorubicin—sarcoma	0.00223	0.00229	CcSEcCtD
Ezogabine—Asthenia—Etoposide—sarcoma	0.00223	0.00228	CcSEcCtD
Ezogabine—Urethral disorder—Doxorubicin—sarcoma	0.00222	0.00227	CcSEcCtD
Ezogabine—Nausea—Mitoxantrone—sarcoma	0.00222	0.00227	CcSEcCtD
Ezogabine—Visual impairment—Doxorubicin—sarcoma	0.00218	0.00224	CcSEcCtD
Ezogabine—Alopecia—Epirubicin—sarcoma	0.00216	0.00222	CcSEcCtD
Ezogabine—Mental disorder—Epirubicin—sarcoma	0.00215	0.0022	CcSEcCtD
Ezogabine—Malnutrition—Epirubicin—sarcoma	0.00213	0.00218	CcSEcCtD
Ezogabine—Eye disorder—Doxorubicin—sarcoma	0.00212	0.00217	CcSEcCtD
Ezogabine—Dizziness—Etoposide—sarcoma	0.00205	0.0021	CcSEcCtD
Ezogabine—Muscle spasms—Epirubicin—sarcoma	0.00205	0.0021	CcSEcCtD
Ezogabine—Vision blurred—Epirubicin—sarcoma	0.00201	0.00206	CcSEcCtD
Ezogabine—Alopecia—Doxorubicin—sarcoma	0.002	0.00205	CcSEcCtD
Ezogabine—Mental disorder—Doxorubicin—sarcoma	0.00198	0.00203	CcSEcCtD
Ezogabine—Ill-defined disorder—Epirubicin—sarcoma	0.00198	0.00203	CcSEcCtD
Ezogabine—Malnutrition—Doxorubicin—sarcoma	0.00197	0.00202	CcSEcCtD
Ezogabine—Rash—Etoposide—sarcoma	0.00196	0.002	CcSEcCtD
Ezogabine—Dermatitis—Etoposide—sarcoma	0.00195	0.002	CcSEcCtD
Ezogabine—Malaise—Epirubicin—sarcoma	0.00192	0.00197	CcSEcCtD
Ezogabine—Vertigo—Epirubicin—sarcoma	0.00192	0.00196	CcSEcCtD
Ezogabine—Syncope—Epirubicin—sarcoma	0.00191	0.00196	CcSEcCtD
Ezogabine—Leukopenia—Epirubicin—sarcoma	0.00191	0.00195	CcSEcCtD
Ezogabine—Muscle spasms—Doxorubicin—sarcoma	0.0019	0.00194	CcSEcCtD
Ezogabine—Loss of consciousness—Epirubicin—sarcoma	0.00187	0.00192	CcSEcCtD
Ezogabine—Vision blurred—Doxorubicin—sarcoma	0.00186	0.0019	CcSEcCtD
Ezogabine—Nausea—Etoposide—sarcoma	0.00184	0.00189	CcSEcCtD
Ezogabine—Ill-defined disorder—Doxorubicin—sarcoma	0.00183	0.00187	CcSEcCtD
Ezogabine—Anxiety—Epirubicin—sarcoma	0.00181	0.00185	CcSEcCtD
Ezogabine—Discomfort—Epirubicin—sarcoma	0.00179	0.00184	CcSEcCtD
Ezogabine—Malaise—Doxorubicin—sarcoma	0.00178	0.00182	CcSEcCtD
Ezogabine—Dry mouth—Epirubicin—sarcoma	0.00177	0.00182	CcSEcCtD
Ezogabine—Vertigo—Doxorubicin—sarcoma	0.00177	0.00181	CcSEcCtD
Ezogabine—Syncope—Doxorubicin—sarcoma	0.00177	0.00181	CcSEcCtD
Ezogabine—Leukopenia—Doxorubicin—sarcoma	0.00177	0.00181	CcSEcCtD
Ezogabine—Confusional state—Epirubicin—sarcoma	0.00175	0.0018	CcSEcCtD
Ezogabine—Loss of consciousness—Doxorubicin—sarcoma	0.00173	0.00178	CcSEcCtD
Ezogabine—Infection—Epirubicin—sarcoma	0.00173	0.00177	CcSEcCtD
Ezogabine—Shock—Epirubicin—sarcoma	0.00171	0.00175	CcSEcCtD
Ezogabine—Nervous system disorder—Epirubicin—sarcoma	0.00171	0.00175	CcSEcCtD
Ezogabine—Thrombocytopenia—Epirubicin—sarcoma	0.0017	0.00174	CcSEcCtD
Ezogabine—Hyperhidrosis—Epirubicin—sarcoma	0.00168	0.00172	CcSEcCtD
Ezogabine—Anxiety—Doxorubicin—sarcoma	0.00167	0.00171	CcSEcCtD
Ezogabine—Discomfort—Doxorubicin—sarcoma	0.00166	0.0017	CcSEcCtD
Ezogabine—Dry mouth—Doxorubicin—sarcoma	0.00164	0.00168	CcSEcCtD
Ezogabine—Confusional state—Doxorubicin—sarcoma	0.00162	0.00166	CcSEcCtD
Ezogabine—Infection—Doxorubicin—sarcoma	0.0016	0.00164	CcSEcCtD
Ezogabine—Shock—Doxorubicin—sarcoma	0.00158	0.00162	CcSEcCtD
Ezogabine—Nervous system disorder—Doxorubicin—sarcoma	0.00158	0.00162	CcSEcCtD
Ezogabine—Thrombocytopenia—Doxorubicin—sarcoma	0.00158	0.00161	CcSEcCtD
Ezogabine—Paraesthesia—Epirubicin—sarcoma	0.00156	0.0016	CcSEcCtD
Ezogabine—Hyperhidrosis—Doxorubicin—sarcoma	0.00156	0.00159	CcSEcCtD
Ezogabine—Dyspnoea—Epirubicin—sarcoma	0.00155	0.00159	CcSEcCtD
Ezogabine—Somnolence—Epirubicin—sarcoma	0.00155	0.00158	CcSEcCtD
Ezogabine—Dyspepsia—Epirubicin—sarcoma	0.00153	0.00157	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Epirubicin—sarcoma	0.0015	0.00154	CcSEcCtD
Ezogabine—Fatigue—Epirubicin—sarcoma	0.0015	0.00154	CcSEcCtD
Ezogabine—Constipation—Epirubicin—sarcoma	0.00149	0.00152	CcSEcCtD
Ezogabine—Paraesthesia—Doxorubicin—sarcoma	0.00145	0.00148	CcSEcCtD
Ezogabine—Dyspnoea—Doxorubicin—sarcoma	0.00144	0.00147	CcSEcCtD
Ezogabine—Feeling abnormal—Epirubicin—sarcoma	0.00143	0.00147	CcSEcCtD
Ezogabine—Somnolence—Doxorubicin—sarcoma	0.00143	0.00147	CcSEcCtD
Ezogabine—Dyspepsia—Doxorubicin—sarcoma	0.00142	0.00145	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00139	0.00142	CcSEcCtD
Ezogabine—Fatigue—Doxorubicin—sarcoma	0.00139	0.00142	CcSEcCtD
Ezogabine—Constipation—Doxorubicin—sarcoma	0.00138	0.00141	CcSEcCtD
Ezogabine—Feeling abnormal—Doxorubicin—sarcoma	0.00133	0.00136	CcSEcCtD
Ezogabine—Asthenia—Epirubicin—sarcoma	0.00125	0.00128	CcSEcCtD
Ezogabine—Asthenia—Doxorubicin—sarcoma	0.00115	0.00118	CcSEcCtD
Ezogabine—Dizziness—Epirubicin—sarcoma	0.00115	0.00118	CcSEcCtD
Ezogabine—Rash—Epirubicin—sarcoma	0.0011	0.00112	CcSEcCtD
Ezogabine—Dermatitis—Epirubicin—sarcoma	0.0011	0.00112	CcSEcCtD
Ezogabine—Dizziness—Doxorubicin—sarcoma	0.00106	0.00109	CcSEcCtD
Ezogabine—Nausea—Epirubicin—sarcoma	0.00103	0.00106	CcSEcCtD
Ezogabine—Rash—Doxorubicin—sarcoma	0.00101	0.00104	CcSEcCtD
Ezogabine—Dermatitis—Doxorubicin—sarcoma	0.00101	0.00104	CcSEcCtD
Ezogabine—Nausea—Doxorubicin—sarcoma	0.000956	0.000979	CcSEcCtD
